These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28937054)

  • 1. The importance of bone biopsy in chronic kidney disease-Mineral bone disorders.
    Dousdampanis P; Trigka K
    Saudi J Kidney Dis Transpl; 2017; 28(5):992-996. PubMed ID: 28937054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of bone biopsy for the diagnosis of renal osteodystrophy: a short overview and future perspectives.
    Carvalho C; Alves CM; Frazão JM
    J Nephrol; 2016 Oct; 29(5):617-26. PubMed ID: 27473148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific measurement of PTH (1-84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry.
    Lehmann G; Stein G; Hüller M; Schemer R; Ramakrishnan K; Goodman WG
    Kidney Int; 2005 Sep; 68(3):1206-14. PubMed ID: 16105052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone Biopsy Results in Chronic Kidney Disease: a Single-Center Experience.
    Liangos O; Kirchhoff S; Buchholz J; Ketteler M
    Kidney Blood Press Res; 2018; 43(4):1222-1230. PubMed ID: 30071519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on the role of bone biopsy in the management of patients with CKD-MBD.
    Evenepoel P; Behets GJS; Laurent MR; D'Haese PC
    J Nephrol; 2017 Oct; 30(5):645-652. PubMed ID: 28831679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of bone biopsy in renal osteodystrophy.
    Al Badr W; Martin KJ
    Saudi J Kidney Dis Transpl; 2009 Jan; 20(1):12-9. PubMed ID: 19112214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone histomorphometry and biochemical markers of bone turnover in patients with chronic kidney disease Stages 3 - 5.
    Lehmann G; Ott U; Kaemmerer D; Schuetze J; Wolf G
    Clin Nephrol; 2008 Oct; 70(4):296-305. PubMed ID: 18826854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone biopsy in nephrology practice.
    Barreto FC; Costa CRVD; Reis LMD; Custódio MR
    J Bras Nefrol; 2018; 40(4):366-374. PubMed ID: 30525179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The complexity of chronic kidney disease-mineral and bone disorder across stages of chronic kidney disease.
    Graciolli FG; Neves KR; Barreto F; Barreto DV; Dos Reis LM; Canziani ME; Sabbagh Y; Carvalho AB; Jorgetti V; Elias RM; Schiavi S; Moysés RMA
    Kidney Int; 2017 Jun; 91(6):1436-1446. PubMed ID: 28318623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone biopsy practice patterns across Europe: the European renal osteodystrophy initiative-a position paper.
    Evenepoel P; D'Haese P; Bacchetta J; Cannata-Andia J; Ferreira A; Haarhaus M; Mazzaferro S; Lafage Proust MH; Salam S; Spasovski G; Cozzolino M;
    Nephrol Dial Transplant; 2017 Oct; 32(10):1608-1613. PubMed ID: 28339949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the noninvasive diagnosis of renal osteodystrophy.
    Moorthi RN; Moe SM
    Kidney Int; 2013 Nov; 84(5):886-94. PubMed ID: 23802194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study.
    Haarhaus M; Monier-Faugere MC; Magnusson P; Malluche HH
    Am J Kidney Dis; 2015 Jul; 66(1):99-105. PubMed ID: 25843703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic Activation of Activin A Signaling Causes Chronic Kidney Disease-Mineral Bone Disorder.
    Sugatani T
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New worldwide trends in presentation of renal osteodystrophy and its relationship to parathyroid hormone levels.
    Gal-Moscovici A; Popovtzer MM
    Clin Nephrol; 2005 Apr; 63(4):284-9. PubMed ID: 15847255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic accuracy study comparing total alkaline phosphatase with intact parathyroid hormone 1-84 for the diagnosis of high turnover renal osteodystrophy in chronic renal failure on hemodialysis].
    Rojas González AM; Opazo Valenzuela M; Muñoz Navarro S
    Medwave; 2014 Sep; 14(8):e6014. PubMed ID: 25340338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis.
    Sprague SM; Bellorin-Font E; Jorgetti V; Carvalho AB; Malluche HH; Ferreira A; D'Haese PC; Drüeke TB; Du H; Manley T; Rojas E; Moe SM
    Am J Kidney Dis; 2016 Apr; 67(4):559-66. PubMed ID: 26321176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of renal osteodystrophy by bone biopsy. Age as an independent factor. Diagnostic value of bone remodeling markers].
    Jarava C; Armas JR; Palma A
    Nefrologia; 2000; 20(4):362-72. PubMed ID: 11039262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current concepts and management strategies in chronic kidney disease-mineral and bone disorder.
    Chauhan V; Kelepouris E; Chauhan N; Vaid M
    South Med J; 2012 Sep; 105(9):479-85. PubMed ID: 22948328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Kidney and bone update : the 5-year history and future of CKD-MBD. Bone metabolic marker in hemodialysis patients update].
    Okuno S
    Clin Calcium; 2012 Jul; 22(7):1009-17. PubMed ID: 22750933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal osteodystrophy in predialysis and hemodialysis patients: comparison of histologic patterns and diagnostic predictivity of intact PTH.
    Coen G; Ballanti P; Bonucci E; Calabria S; Costantini S; Ferrannini M; Giustini M; Giordano R; Nicolai G; Manni M; Sardella D; Taggi F
    Nephron; 2002 May; 91(1):103-11. PubMed ID: 12021526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.